I am joined by Simon Arkell, Co-Founder and CEO of Ryght, a pioneering company in the healthcare ecosystem that specializes in producing generative AI solutions that cater specifically to the needs of drug companies.
Simon sheds light on the nuances between AI and traditional machine learning models, highlighting Ryght’s innovative approach to making generative AI both accessible and secure. He expands on the intricacies of data synthesis, drawing from diverse sources to craft individualized models for each client. Simon further shares how customer feedback has been instrumental in refining Ryght’s offerings, ultimately shaping the future of healthcare innovation.
For more information about Ryght, visit their website.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
